Core Viewpoint - BlackRock, Inc. (BLK) is expected to report strong earnings growth, with analysts projecting a profit increase for the upcoming fiscal first-quarter earnings announcement for 2026 [1][2]. Earnings Expectations - Analysts anticipate BLK will report earnings of $12.36 per share for Q1 2026, reflecting a 9.4% increase from $11.30 per share in the same quarter last year [2]. - For the full fiscal year 2026, EPS is expected to reach $53.64, an 11.5% increase from $48.09 in fiscal 2025, with further growth projected to $61.73 in fiscal 2027, representing a 15.1% year-over-year increase [3]. Earnings History - BLK has consistently exceeded Wall Street's EPS estimates in its last four quarterly reports, with reported EPS of $11.30, $12.05, $11.55, and $13.16 for the quarters ending in March, June, September, and December 2025, respectively [4]. - The company has shown positive surprises in earnings, with the most recent quarter (Q4 2025) reporting an adjusted EPS of $13.16, surpassing expectations of $12.39 [5]. Stock Performance - Over the past 52 weeks, BLK stock has underperformed the S&P 500 Index, which gained 13.7%, with BLK shares only increasing by 1.3%. However, it outperformed the State Street Financial Select Sector SPDR ETF, which saw a 1.7% loss during the same period [4]. Analyst Ratings - The consensus among analysts is moderately bullish, with a "Moderate Buy" rating overall. Out of 18 analysts, 12 recommend a "Strong Buy," 2 suggest a "Moderate Buy," 3 give a "Hold," and 1 recommends a "Moderate Sell" [6]. - The average analyst price target for BLK is $1,315.94, indicating a potential upside of 34.8% from current levels [6].

Core Viewpoint - Invesco Ltd. (IVZ) is a significant player in the asset management industry, with a market capitalization of $10.3 billion, and has shown strong performance over the past year despite recent stock price fluctuations [1][2]. Financial Performance - Invesco's operating revenue for Q4 2025 increased by 6.2% year-over-year to $1.7 billion, exceeding market expectations [7]. - The adjusted earnings per share (EPS) for the quarter was $0.62, also surpassing Wall Street estimates [7]. Stock Performance - IVZ stock has experienced a decline of 19.7% from its 52-week high of $29.61, reached on January 22, and is down 12.3% over the past three months, underperforming the S&P 500 Index's decline of 4.8% during the same period [3]. - Over the past 52 weeks, IVZ stock has surged by 55.2%, significantly outperforming the S&P 500's return of 16.1% [6]. Market Position - Invesco is categorized as a large-cap stock due to its market capitalization exceeding $10 billion, reflecting its substantial size and influence in the asset management sector [2]. - Compared to its peer, T. Rowe Price Group, Inc. (TROW), Invesco has outperformed, as TROW stock has declined by 5.2% over the past year [8]. Analyst Sentiment - The consensus rating among 13 analysts covering IVZ is a "Moderate Buy," with a mean price target of $30.29, indicating a potential upside of 27.4% from current price levels [8].

Core Viewpoint - AllianceBernstein Holding L.P. is recognized as one of the most undervalued financial stocks, with a notable increase in assets under management (AUM) and strong performance in various investment areas [1][2]. Group 1: Financial Performance - As of February 2026, AllianceBernstein's AUM rose to $880 billion, up from $875 billion at the end of January, reflecting a 0.6% increase driven by market appreciation, despite modest net outflows [1]. - The company reported Q4 adjusted EPS of 96 cents, surpassing the consensus estimate of 92 cents, with revenue reaching $1.22 billion compared to the consensus of $956.06 million [2]. - In 2025, AllianceBernstein achieved a record AUM of $867 billion and generated over $140 billion in sales, despite experiencing net outflows in active equities [2]. Group 2: Strategic Insights - CEO Seth Bernstein highlighted 2025 as a year of disciplined execution and strategic progress, emphasizing the firm's efforts to broaden its platform and deepen client relationships [2]. - The firm noted significant organic growth in areas such as ultra-high-net-worth, insurance, separately managed accounts, active ETFs, and private markets, with private markets AUM increasing by 18% year over year to reach $82 billion [2]. Group 3: Market Position - Evercore ISI adjusted its price target for AllianceBernstein to $41 from $43 while maintaining an Outperform rating, reflecting a reassessment of the asset manager's flows for February and Q1 [2]. - AllianceBernstein operates as a publicly owned investment manager, providing services to a diverse range of clients including investment companies, pension plans, banks, and individuals [3].

Group 1: Company Performance - Invesco Ltd. reported preliminary month-end assets under management (AUM) of $2.26 trillion for February 2026, reflecting a 1.2% increase from the previous month [1] - The firm experienced net long-term inflows of $4.7 billion in February, alongside $13.5 billion in net inflows from money market strategies [1] - Invesco's Q4 adjusted EPS was 62 cents, surpassing the consensus estimate of 58 cents, with revenue of $1.26 billion compared to the consensus of $1.25 billion [3] Group 2: Market Analysis - Analyst Glenn Schorr from Evercore ISI reduced the price target for Invesco Ltd. to $29 from $31 while maintaining an In Line rating, following an analysis of asset manager flows for February and Q1 [2] - Favorable market returns contributed an increase of $9 billion to AUM, although this was partially offset by a $1.1 billion negative impact from foreign exchange [1]

Core Insights - U.S. small-cap equities experienced modest gains in Q4 2025, supported by attractive valuations, earnings recovery, and a shift from mega-cap stocks [1] - The Aristotle Small Cap Equity Fund (Class I-2) returned 1.96% in Q4 2025, slightly trailing the Russell 2000 Index's return of 2.19% [1] - Security selection positively impacted overall performance, while allocation effects detracted from it [1] Company Focus: Cohen & Steers, Inc. (NYSE:CNS) - Cohen & Steers, Inc. is a leading asset management holding company with a market capitalization of $3.4 billion [2] - The stock closed at $66.66 per share on February 13, 2026, with a one-month return of -5.34% and a twelve-month decline of 21.82% [2] - The company has seen an improvement in new business activity due to lower interest rates and high equity market valuations, which may lead to earnings growth [3] - Cohen & Steers maintains solid cash levels, positioning it for potential acquisitions or share repurchases [3] Hedge Fund Interest - Cohen & Steers, Inc. was held by 27 hedge fund portfolios at the end of Q3 2025, an increase from 23 in the previous quarter [5] - Despite its potential, the company is not among the 30 most popular stocks among hedge funds, with some analysts suggesting that certain AI stocks may offer better upside potential [5]

Company Overview - Franklin Resources, Inc. is a global investment management company headquartered in San Mateo, CA, primarily generating revenue from investment management services for retail mutual funds, institutional, and high-net-worth investors worldwide [11]. Zacks Rank and Style Scores - Franklin Resources has a Zacks Rank of 3 (Hold) and a VGM Score of B, indicating a moderate investment outlook [12]. - The company has a Momentum Style Score of A, with shares increasing by 7.5% over the past four weeks [12]. - For fiscal 2026, three analysts have revised their earnings estimates upwards in the last 60 days, with the Zacks Consensus Estimate rising by $0.03 to $2.54 per share [12]. - Franklin Resources has an average earnings surprise of +11.7%, suggesting a positive trend in earnings performance [12]. Investment Considerations - With a solid Zacks Rank and strong Momentum and VGM Style Scores, Franklin Resources is recommended for investors' consideration [13].

Core Insights - Goldman Sachs is recognized as one of the 12 Best DOW Stocks to Buy in 2026 [1] - Barclays has raised its price target for Goldman Sachs to $1,048 from $850, maintaining an Overweight rating, anticipating continued earnings growth into 2026 [2] - Goldman Sachs topped global dealmaking league tables in 2025, driven by significant political events and an increase in larger transactions [3] Financial Performance - The year 2025 saw 68 transactions exceeding $10 billion, totaling $1.5 trillion, more than double the previous year, with Goldman advising on 38 of these deals, amounting to $1.48 trillion in advised volume [4] - Goldman Sachs collected $4.6 billion in M&A fees, ranking No. 1 in both M&A fee revenue and total deal value, leading in deal volume ahead of JPMorgan and Morgan Stanley [6] - In the EMEA region, Goldman achieved a market share of 44.7% in 2025, a level not seen since 1999 [6] Market Outlook - Goldman Sachs' Global Co-Head of M&A described 2025 as an "exceptional M&A year," attributing the strong market to a "ubiquity of capital" [5] - Barclays expects the factors that contributed to double-digit earnings growth and bank stock outperformance in 2025 to persist into 2026 [2]

Market Overview - The U.S. markets ended the final trading week of 2025 on a mixed note, with optimism over AI growth offset by caution regarding Federal Reserve policy signals [1] - Despite thin year-end liquidity, late pullbacks in all three major benchmark indexes kept the broader bull trend intact as market participants positioned for 2026 [1] Macroeconomic Indicators - Initial jobless claims fell unexpectedly by 16,000 to a seasonally adjusted 199,000 for the week ended Dec. 27, the lowest since the end of November, signaling continued labor market strength [2] - Pending home sales unexpectedly rose 3.3% in November, marking the largest seasonal rise since 2023 [2] Federal Reserve Policy - The Fed has successfully kept inflation stable and near its 2% target, with a current overnight borrowing rate in the range of 3.50-3.75% [3] - The pace of further easing may slow, even though markets are expecting two additional quarter-point cuts in 2026 [3] Dividend-Paying Stocks - Investors looking to diversify their portfolios can consider dividend-paying stocks, which indicate a healthy business model and can counter market upheavals [4] - Stocks that have raised dividends recently tend to outperform non-dividend-paying entities in a highly volatile market [4] Company Highlights The Ensign Group - The Ensign Group provides health care services in the post-acute care continuum and has a Zacks Rank 2 (Buy) [5] - On Dec. 19, ENSG declared a dividend of 7 cents a share, with a dividend yield of 0.1% [5] - Over the past five years, ENSG has increased its dividend five times, with a payout ratio of 4% of earnings [6] Invesco Mortgage Capital - Invesco Mortgage Capital is a real estate investment trust with a Zacks Rank 1 (Strong Buy) [7] - On Dec. 18, IVR declared a dividend of 36 cents a share, reflecting a dividend yield of 17.3% [7] - IVR has increased its dividend four times in the past five years, with a payout ratio of 58% of earnings [8] ABM Industries - ABM Industries is a provider of integrated facility solutions with a Zacks Rank 3 (Hold) [9] - On Dec. 17, ABM announced a dividend of 29 cents a share, yielding 2.5% [9] - Over the past five years, ABM has increased its dividend six times, with a payout ratio of 31% of earnings [11] Franklin Resources - Franklin Resources is a global investment management company with a Zacks Rank 3 [12] - On Dec. 17, BEN declared a dividend of 33 cents a share, yielding 5.5% [12] - Over the past five years, BEN has increased its dividend five times, with a payout ratio of 58% of earnings [13] Norwood Financial - Norwood Financial is a bank holding company with a Zacks Rank 3 [14] - On Dec. 16, NWFL announced a dividend of 32 cents a share, yielding 4.4% [14] - Over the past five years, NWFL has increased its dividend six times, with a payout ratio of 47% of earnings [14]

Core Insights - The article emphasizes the importance of investing in large-cap high-yield dividend stocks as a strategy for growth and income, particularly in the current volatile market environment [4][6]. Company Summaries - **ConocoPhillips**: This exploration and production company has a dividend yield of 3.57% and recently completed a $22.5 billion acquisition of Marathon Oil, enhancing its asset portfolio in key shale regions [8][10]. - **Ford Motor Co.**: An American automotive corporation with a 4.83% dividend yield, Ford operates in multiple segments, including commercial vehicles and financing services [11][14]. - **Johnson & Johnson**: A diversified healthcare giant with a 2.60% dividend yield, trading at 14.5 times forward earnings, noted for its strong brand and conservative approach in pharmaceuticals [15][17]. - **Prudential Financial**: This company offers a 5.04% dividend yield and provides a range of insurance and investment management services, making it a safe option for conservative investors [18][23]. - **Verizon Communications**: With a 6.63% dividend yield and trading at 9.13 times estimated 2026 earnings, Verizon has a stable revenue stream and a strong interest coverage ratio of 4.6 to 5.0 times, supporting its dividend payments [24][25].

Core Points - Mount Logan Capital Inc. will release its financial results for Q3 2025 on November 13, 2025, after market close [1] - A conference call to discuss the financial results will be held on November 14, 2025, at 10:00 a.m. Eastern Time [1] - The company focuses on public and private debt securities in North America and reinsurance of annuity products [2] Company Overview - Mount Logan Capital Inc. is an alternative asset management and insurance solutions company [2] - The company primarily invests in loans, debt securities, and credit-oriented instruments that offer attractive risk-adjusted returns [2] - ML Management, a subsidiary, provides investment management services to various investment funds and acts as a collateral manager for collateralized loan obligations [3] Subsidiary Information - Ability Insurance Company, acquired in Q4 FY 2021, reinsures long-term care policies and annuity products but no longer insures new long-term care risks [4]